TGFB1 and oral lichen planus: Considering the potential pro-tumorigenic interaction between NF-κB and CD163+ cells, this hypothesis could suggest that alternative therapeutic agents could modulate the immune response in OLP attenuating the inductive effect of the epithelial NF-κB on the interface inflammatory response and regulating the action of TGF-β (43).